Advanced search
Publication Cover
Current Medical Research and Opinion Volume 29, 2013 - Issue 12
Submit an article Journal homepage
392
Views
12
CrossRef citations to date
0
Altmetric
Respiratory Diseases: Original article

Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma

Neil G. SnowiseVectura Group plc, Chippenham WiltshireUK
,
Diane ClementsGlaxoSmithKline Research Triangle Park, NCUSA
,
Shu-Yen HoGlaxoSmithKline Research Triangle Park, NCUSA
&
Richard M.A. FollowsGlaxoSmithKline Uxbridge, MiddlesexUKCorrespondence[email protected]
Pages 1663-1674 | Accepted 04 Sep 2013, Published online: 19 Sep 2013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.